(Q55175731)

English

Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial.

scientific article published on 27 April 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

24 June 2018

http://europepmc.org/abstract/PMC/5931194

Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial. (English)

1 reference

Europe PubMed Central

PMC publication ID

24 June 2018

http://europepmc.org/abstract/PMC/5931194

steatohepatitis

0 references

author name string

Shahinul Alam

1

1 reference

Europe PubMed Central

PMC publication ID

24 June 2018

http://europepmc.org/abstract/PMC/5931194

Jhumur Ghosh

2

1 reference

Europe PubMed Central

PMC publication ID

24 June 2018

http://europepmc.org/abstract/PMC/5931194

Golam Mustafa

3

1 reference

Europe PubMed Central

PMC publication ID

24 June 2018

http://europepmc.org/abstract/PMC/5931194

Mohammad Kamal

4

1 reference

Europe PubMed Central

PMC publication ID

24 June 2018

http://europepmc.org/abstract/PMC/5931194

Nooruddin Ahmad

5

1 reference

Europe PubMed Central

PMC publication ID

24 June 2018

http://europepmc.org/abstract/PMC/5931194

publication date

27 April 2018

1 reference

Europe PubMed Central

PMC publication ID

24 June 2018

http://europepmc.org/abstract/PMC/5931194

Hepatic Medicine: Evidence and Research

1 reference

Europe PubMed Central

PMC publication ID

24 June 2018

http://europepmc.org/abstract/PMC/5931194

10

1 reference

Europe PubMed Central

PMC publication ID

24 June 2018

http://europepmc.org/abstract/PMC/5931194

23-31

1 reference

Europe PubMed Central

PMC publication ID

24 June 2018

http://europepmc.org/abstract/PMC/5931194

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 April 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Sitagliptin can inhibit the development of hepatic steatosis in high-fructose diet-fed ob/ob mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Novel anti-diabetic agents in non-alcoholic fatty liver disease: a mini-review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Dipeptidyl peptidase-4: a key player in chronic liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Nonalcoholic steatohepatitis: a review of the literature and updates in management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Hepatocellular ballooning in NASH.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Managing nonalcoholic fatty liver disease: recommendations for family physicians.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Effect of thiazolidinediones on body weight in patients with diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

Occupancy of dipeptidyl peptidase IV activates an associated tyrosine kinase and triggers an apoptotic signal in human hepatocarcinoma cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

24 June 2018

CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

13 August 2018

Plasma concentrations of zinc, copper, interleukin-6 and interferon-γ, and plasma dipeptidyl peptidase IV activity in chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

13 August 2018

Dipeptidyl peptidase IV (DDP IV) in NASH patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

13 August 2018

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

13 August 2018

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

13 August 2018

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5931194

13 August 2018

Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29740221

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/29740221

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sitagliptin prevents the development of metabolic and hormonal disturbances, increased β-cell apoptosis and liver steatosis induced by a fructose-rich diet in normal rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/29740221

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/29740221

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of sitagliptin in diabetic patients with nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29740221

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2147/HMER.S158053

1 reference

Europe PubMed Central

PMC publication ID

24 June 2018

http://europepmc.org/abstract/PMC/5931194

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

24 June 2018

http://europepmc.org/abstract/PMC/5931194

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

24 June 2018

http://europepmc.org/abstract/PMC/5931194

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55175731&oldid=1895117019"